Radnor Capital Management, LLC Merck & Co., Inc. Transaction History
Radnor Capital Management, LLC
- $597 Million
- Q1 2025
A detailed history of Radnor Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Radnor Capital Management, LLC holds 507,498 shares of MRK stock, worth $40.1 Million. This represents 7.63% of its overall portfolio holdings.
Number of Shares
507,498
Previous 520,766
2.55%
Holding current value
$40.1 Million
Previous $51.8 Million
12.07%
% of portfolio
7.63%
Previous 8.66%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,934Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.55 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.83 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.49 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $200B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...